Literature DB >> 16157836

Analgesic use and risk of subsequent hypertension in apparently healthy men.

Tobias Kurth1, Charles H Hennekens, Til Stürmer, Howard D Sesso, Robert J Glynn, Julie E Buring, J Michael Gaziano.   

Abstract

BACKGROUND: Prospective studies have suggested that women who self-select for use of analgesics have an increased risk of hypertension, but data in men are sparse. We tested whether apparently healthy male physicians who reported analgesic use had an increased risk of subsequent hypertension.
METHODS: Prospective cohort study of 8229 participants in the Physicians' Health Study who were free of hypertension and completed detailed analgesic questionnaires. Hypertension was defined as self-reported blood pressure of 140/90 mm Hg or higher or use of antihypertensive medication.
RESULTS: After a mean of 5.8 years' follow-up, 2234 men (27.2%) reported subsequent hypertension. We categorized the cumulative analgesic use in quintiles. After adjusting for potential confounders, men in the highest quintile had no statistically significant increased risk of hypertension (hazard ratio, 1.12; 95% confidence interval, 0.97-1.31) when compared with those in the lowest quintile. In subgroup analyses, we evaluated the cumulative use of nonsteroidal anti-inflammatory drugs, acetaminophen, and aspirin. Compared with never users, men who reported consuming at least 2500 pills had hazard ratios of 1.05 (95% confidence interval, 0.89-1.24) for nonsteroidal anti-inflammatory drugs, 1.08 (95% confidence interval, 0.87-1.34) for acetaminophen, and 1.16 (95% confidence interval, 0.92-1.48) for aspirin. The results were similar for analgesic use in the year preceding the analgesic questionnaire.
CONCLUSION: In this large cohort, apparently healthy male physicians who self-selected for analgesic use had no significantly increased risk of subsequent hypertension, although a small to moderately increased risk cannot be excluded in observational studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157836     DOI: 10.1001/archinte.165.16.1903

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

Review 1.  Antihypertensive effects of aspirin: what is the evidence?

Authors:  Leonelo E Bautista; Lina M Vera
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  Does paracetamol cause hypertension?

Authors:  Brett Montgomery
Journal:  BMJ       Date:  2008-05-24

Review 3.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

4.  Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.

Authors:  Luke S Vest; Nagaraju Sarabu; Farrukh M Koraishy; Minh-Tri Nguyen; Meyeon Park; Ngan N Lam; Mark A Schnitzler; David Axelrod; Chi Yuan Hsu; Amit X Garg; Dorry L Segev; Allan B Massie; Gregory P Hess; Bertram L Kasiske; Krista L Lentine
Journal:  Clin Transplant       Date:  2020-06-29       Impact factor: 2.863

Review 5.  A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects.

Authors:  Emma J Turtle; James W Dear; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

6.  Treatment strategies for osteoarthritis patients with pain and hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Paola Martire; Marta Garofoli; Giorgio Gentile; Gianpaolo Reboldi
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

Review 7.  Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.

Authors:  Matthias Hermann
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 8.  Long-term adverse effects of paracetamol - a review.

Authors:  J C McCrae; E E Morrison; I M MacIntyre; J W Dear; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

9.  Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.

Authors:  Louise Profit; Paul Chrisp
Journal:  Core Evid       Date:  2007-11-30

10.  Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension.

Authors:  Hisham Aljadhey; Wanzhu Tu; Richard A Hansen; Susan J Blalock; D Craig Brater; Michael D Murray
Journal:  BMC Cardiovasc Disord       Date:  2012-10-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.